tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Cash flow

Compare
611 Followers

MoonLake Immunotherapeutics Cash Flow

MLTX's free cash flow for Q3 2025 was $-44.54M. For the 2025 fiscal year, MLTX's free cash flow was decreased by $-74.04M and operating cash flow was $-44.54M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -116.59M$ -42.78M$ -55.89M$ -35.18M$ -316.69K
Investing Cash Flow
$ -205.60M$ -25.18M$ -32.34M$ -50.71K$ -115.00M
Financing Cash Flow
$ 51.31M$ 479.70M$ 119.69M$ 43.26M$ 116.65M
End Cash Position
$ 180.43M$ 451.17M$ 39.51M$ 8.04M$ 1.34M
Free Cash Flow
$ -117.11M$ -43.06M$ -55.91M$ -35.23M$ -316.69K
Currency in USD

MoonLake Immunotherapeutics Cash Flow